利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

169 条记录 (耗时 0.058 秒)

    Time synchronization of femtocell
    43.
    发明授权
    Time synchronization of femtocell 有权
    毫微微小区的时间同步

    公开(公告)号：US08213391B2

    公开(公告)日：2012-07-03

    申请号：US12143924

    申请日：2008-06-23

    申请人： Stanislaw Czaja ,  Mark E. Davis ,  Anthony Lee ,  Sang Gook Kim ,  Li-Hsiang Sun

    发明人： Stanislaw Czaja ,  Mark E. Davis ,  Anthony Lee ,  Sang Gook Kim ,  Li-Hsiang Sun

    IPC分类号： H04B7/216 ,  H04J3/06

    CPC分类号： H04L7/041 ,  H04W24/02 ,  H04W56/0015 ,  H04W84/045

    摘要： Time synchronization of an access point base station. The method may include receiving an assignment message from a service provider comprising a plurality of parameters. The plurality of parameters may include an access point base station frequency assignment, a network identifier, an access point base station identifier, a neighbor list, a PN offset, and/or a scrambling code. The access point base station may then synchronize with the macro base station. Synchronizing may include searching for a strongest macro base station in the neighbor list, synchronizing a long code of the access point base station to the macro base station, estimating a propagation delay between the macro base station and the access point base station, and initializing a state of the access point base station PN code using the propagation delay to provide system time synchronization.

    摘要翻译： 接入点基站的时间同步。 该方法可以包括从包括多个参数的服务提供商接收分配消息。 多个参数可以包括接入点基站频率分配，网络标识符，接入点基站标识符，邻居列表，PN偏移和/或扰码。 接入点基站然后可以与宏基站同步。 同步可以包括在邻居列表中搜索最强的宏基站，将接入点基站的长码同步到宏基站，估计宏基站和接入点基站之间的传播延迟，以及初始化 接入点基站PN码的状态使用传播延迟来提供系统时间同步。

    COMPLEXING AGENTS FOR COMPOSITIONS CONTAINING INCLUSION COMPLEXES
    44.
    发明申请
    COMPLEXING AGENTS FOR COMPOSITIONS CONTAINING INCLUSION COMPLEXES 有权
    包含复合物的组合物的复合剂

    公开(公告)号：US20110256104A1

    公开(公告)日：2011-10-20

    申请号：US13107024

    申请日：2011-05-13

    申请人： Suzie Hwang Pun ,  Hector Gonzalez ,  Mark E. Davis ,  Nathalie Bellocq ,  Jianjun Cheng

    发明人： Suzie Hwang Pun ,  Hector Gonzalez ,  Mark E. Davis ,  Nathalie Bellocq ,  Jianjun Cheng

    IPC分类号： A61K35/76 ,  C12N9/96 ,  C12N7/00 ,  C12N15/63 ,  A61K38/14 ,  A61K31/7088 ,  A61K31/718 ,  C07K9/00 ,  C07K19/00 ,  C07K14/00 ,  C08B37/16 ,  A61P21/00 ,  A61P35/04 ,  A61P9/00 ,  A61P31/12 ,  A61K38/54

    CPC分类号： A61K47/48215 ,  A61K38/44 ,  A61K47/60 ,  A61K47/6949 ,  A61K47/6951 ,  A61K48/0041 ,  B82Y5/00 ,  C08B37/0012 ,  C08G65/33396 ,  C08G65/48 ,  C08G2650/04 ,  C08G2650/38 ,  C12Y113/12007

    摘要： The invention provides a composition containing particulate composite of a polymer and a therapeutic agent. The composition also contains a complexing agent. The polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex. A therapeutic composition of the invention may be used to deliver the therapeutic agent and to treat various disorders. Both the polymer of the particulate composite and the complexing agent may be used to introduce functionality into the therapeutic composition. The invention also relates to a method of preparing a composition. The method combines a therapeutic agent, a polymer having host or guest functionality, and a complexing agent having guest or host functionality to form the therapeutic composition. The complexing agent forms an inclusion complex with the polymer. The invention also relates to a method of delivering a therapeutic agent. According to the method, a therapeutically effective amount of a therapeutic composition of the invention is administered to a mammal (e.g. person or animal) in recognized need of the therapeutic. Also disclosed are compounds having the formula:

    摘要翻译： 本发明提供了含有聚合物和治疗剂的颗粒复合物的组合物。 该组合物还含有络合剂。 聚合物与宿主客体或客体 - 宿主相互作用中的络合剂相互作用以形成包合物。 本发明的治疗组合物可用于递送治疗剂并治疗各种疾病。 颗粒复合材料的聚合物和络合剂都可用于将功能性引入治疗组合物中。 本发明还涉及制备组合物的方法。 该方法结合治疗剂，具有宿主或客体功能的聚合物和具有客体或宿主功能的络合剂以形成治疗组合物。 络合剂与聚合物形成包合络合物。 本发明还涉及递送治疗剂的方法。 根据该方法，将治疗有效量的本发明的治疗组合物在公认的治疗需要中给予哺乳动物（例如人或动物）。 还公开了具有下式的化合物：

    Complexing agents for compositions containing inclusion complexes
    45.
    发明授权
    Complexing agents for compositions containing inclusion complexes 有权
    含有复合物的组合物的络合剂

    公开(公告)号：US07968123B2

    公开(公告)日：2011-06-28

    申请号：US11588033

    申请日：2006-10-25

    申请人： Suzie Hwang Pun ,  Hector Gonzalez ,  Mark E. Davis ,  Nathalie C. Bellocq ,  Jianjun Cheng

    发明人： Suzie Hwang Pun ,  Hector Gonzalez ,  Mark E. Davis ,  Nathalie C. Bellocq ,  Jianjun Cheng

    IPC分类号： A61K31/74 ,  A61K9/14 ,  C12P19/30 ,  C12N15/63

    CPC分类号： A61K47/48215 ,  A61K38/44 ,  A61K47/60 ,  A61K47/6949 ,  A61K47/6951 ,  A61K48/0041 ,  B82Y5/00 ,  C08B37/0012 ,  C08G65/33396 ,  C08G65/48 ,  C08G2650/04 ,  C08G2650/38 ,  C12Y113/12007

    摘要： The invention provides a composition containing particulate composite of a polymer and a therapeutic agent. The composition also contains a complexing agent. The polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex. A therapeutic composition of the invention may be used to deliver the therapeutic agent and to treat various disorders. Both the polymer of the particulate composite and the complexing agent may be used to introduce functionality into the therapeutic composition. The invention also relates to a method of preparing a composition. The method combines a therapeutic agent, a polymer having host or guest functionality, and a complexing agent having guest or host functionality to form the therapeutic composition. The complexing agent forms an inclusion complex with the polymer. The invention also relates to a method of delivering a therapeutic agent. According to the method, a therapeutically effective amount of a therapeutic composition of the invention is administered to a mammal (e.g. person or animal) in recognized need of the therapeutic. Also disclosed are compounds having the formula:

    摘要翻译： 本发明提供了含有聚合物和治疗剂的颗粒复合物的组合物。 该组合物还含有络合剂。 聚合物与宿主客体或客体 - 宿主相互作用中的络合剂相互作用以形成包合物。 本发明的治疗组合物可用于递送治疗剂并治疗各种疾病。 颗粒复合材料的聚合物和络合剂都可用于将功能性引入治疗组合物中。 本发明还涉及制备组合物的方法。 该方法结合治疗剂，具有宿主或客体功能的聚合物和具有客体或宿主功能的络合剂以形成治疗组合物。 络合剂与聚合物形成包合络合物。 本发明还涉及递送治疗剂的方法。 根据该方法，将治疗有效量的本发明的治疗组合物在公认的治疗需要中给予哺乳动物（例如人或动物）。 还公开了具有下式的化合物：

    Molecular sieves for improved hydrocarbon traps
    46.
    发明授权
    Molecular sieves for improved hydrocarbon traps 有权
    用于改进烃阱的分子筛

    公开(公告)号：US07858059B2

    公开(公告)日：2010-12-28

    申请号：US11040527

    申请日：2005-01-21

    申请人： Mark E. Davis ,  Tatsuya Okubo

    发明人： Mark E. Davis ,  Tatsuya Okubo

    IPC分类号： B01D53/56

    CPC分类号： B01D53/02 ,  B01D2253/108 ,  B01D2253/30 ,  B01D2257/702 ,  B01D2258/01 ,  B01D2259/40086 ,  F01N3/0814 ,  F01N3/0835 ,  F01N3/0871 ,  F01N3/30 ,  F01N2570/12 ,  Y02T10/20

    摘要： Molecular sieves and the use of such materials as hydrocarbon traps, particularly for reducing the emissions associated with the combustion of hydrocarbon fuels are described. Specifically, the use of molecular sieves such as zeolites as adsorbents for hydrocarbon gases, especially exhaust gases such as are formed during the combustion of hydrocarbons, and more particularly to the adsorption of hydrocarbon gases formed during the cold start operation of an internal combustion engine is described. In one embodiment, a method of treating exhaust gas that comprises a hydrocarbon combustion product is provided, the method comprising contacting the exhaust gas with a CON topology molecular sieve for a time period effective to facilitate adsorption of the hydrocarbon combustion product by the molecular sieve; passing a purge gas through the molecular sieve to remove adsorbed hydrocarbon combustion product; and contacting the purge gas containing the removed hydrocarbon combustion product with a hydrocarbon conversion catalyst.

    摘要翻译： 描述了分子筛和使用这种材料作为烃阱，特别是用于减少与烃燃料的燃烧相关的排放。 具体地说，使用分子筛如沸石作为碳氢化合物气体的吸附剂，特别是在烃的燃烧过程中形成的废气，特别是在内燃机的冷启动操作期间形成的烃气体的吸附， 描述。 在一个实施方案中，提供了一种处理包含烃燃烧产物的废气的方法，所述方法包括使排气与CON拓扑分子筛接触，所述时间段有效地促进通过分子筛吸附烃燃烧产物; 将清洗气体通过分子筛除去吸附的烃燃烧产物; 并将含有去除的烃燃烧产物的吹扫气体与烃转化催化剂接触。

    LOCALIZED SILENCE AREA FOR MOBILE DEVICES
    47.
    发明申请
    LOCALIZED SILENCE AREA FOR MOBILE DEVICES 有权
    用于移动设备的本地化静音区域

    公开(公告)号：US20090298475A1

    公开(公告)日：2009-12-03

    申请号：US12471651

    申请日：2009-05-26

    申请人： Stanislaw Czaja ,  Mark E. Davis

    发明人： Stanislaw Czaja ,  Mark E. Davis

    IPC分类号： H04M3/537 ,  H04W24/00

    CPC分类号： H04W48/04 ,  H04W48/08

    摘要： A system and method for creating a localized silence area. A mobile device may be registered with an access point base station. Any direct communication links from the mobile device to any other base stations may be removed. An indication may be given to the mobile device that the mobile device is in a localized silence zone. The indication may include a request that the mobile device operate in a silent mode, information about making outgoing calls, information about receiving incoming calls, or a combination of these. Procedures for incoming voice calls to the mobile device may be different for different priority levels.

    摘要翻译： 一种用于创建局部静音区域的系统和方法。 移动设备可以向接入点基站注册。 可以移除从移动设备到任何其他基站的任何直接通信链路。 可以向移动设备给出移动设备处于局部静默区域中的指示。 该指示可以包括移动设备以无声模式操作的请求，关于拨出呼叫的信息，关于接收呼入的信息，或这些的组合。 对于不同的优先级，到移动设备的进入语音呼叫的过程可能是不同的。

    Inhibitor Nucleic Acids
    48.
    发明申请
    Inhibitor Nucleic Acids 审中-公开
    抑制剂核酸

    公开(公告)号：US20080234217A1

    公开(公告)日：2008-09-25

    申请号：US11883219

    申请日：2006-01-26

    申请人： Mark E. Davis

    发明人： Mark E. Davis

    IPC分类号： A61K31/70 ,  C07H21/00 ,  A61P43/00

    CPC分类号： A61K31/7125 ,  A61K31/713 ,  C12N15/111 ,  C12N15/113 ,  C12N15/1138 ,  C12N2310/14 ,  C12N2310/16 ,  C12N2310/315 ,  C12N2310/322 ,  C12N2310/3519 ,  C12N2310/53 ,  C12N2320/32 ,  C12N2320/50

    摘要： The present invention provides methods and compositions for attenuating expression of a target gene in vivo. In general, the method includes administering RNAi constructs (such as small-interfering RNAs (i.e., siRNAs) that are targeted to particular mRNA sequences, or nucleic acid material that can produce siRNAs in a cell), in an amount sufficient to attenuate expression of a target gene by an RNA interference mechanism. In particular, the RNAi constructs may include one or more modifications to improve serum stability, cellular uptake and/or to avoid non-specific effect. In certain embodiments, the RNAi constructs contain an aptamer portion. The aptamer may bind to human serum albumin to improve serum half life. The aptamer may also bind to a cell surface protein that improves uptake of the construct.

    摘要翻译： 本发明提供用于在体内减弱靶基因表达的方法和组合物。 一般来说，该方法包括以足以减弱表达的表达的量施用RNAi构建体（例如靶向特定mRNA序列的小干扰RNA（即siRNA）或可在细胞中产生siRNA的核酸材料） 一种RNA干扰机制的靶基因。 特别地，RNAi构建体可以包括一种或多种修饰以改善血清稳定性，细胞摄取和/或避免非特异性效应。 在某些实施方案中，RNAi构建体含有适体部分。 适体可以结合人血清白蛋白以改善血清半衰期。 适体也可以结合细胞表面蛋白，改善构建体的摄取。

    Rollable sports base
    50.
    发明授权
    Rollable sports base 有权
    可滚动的运动场

    公开(公告)号：US07219865B2

    公开(公告)日：2007-05-22

    申请号：US10390181

    申请日：2003-03-18

    申请人： Mark E. Davis ,  Ronald A. White ,  Craig Saunders ,  Rene Polin ,  Keith Kristiansen ,  Michael Ballone ,  Gary Grossman

    发明人： Mark E. Davis ,  Ronald A. White ,  Craig Saunders ,  Rene Polin ,  Keith Kristiansen ,  Michael Ballone ,  Gary Grossman

    IPC分类号： A47K1/04 ,  A63B63/08

    CPC分类号： A63B71/023 ,  A63B63/083 ,  A63B2071/025

    摘要： A rollable sports ballast base for supporting a sports apparatus support member comprising a base member which has a first edge and a second edge, a top surface and a bottom surface. The bottom surface is adapted to contact a support surface such as a driveway or other playing surface. There is at least one wheel assembly for contacting the support surface. One of the wheel assemblies is retractable from a lowered position to a raised position such that when in the raised position, the bottom surface of the base member substantially contacts the support surface. In the lowered position, both wheel assemblies contact the support surface thereby separating or elevating the base member from the support surface. In another embodiment, the invention consists of a similar rollable sports base for supporting a sports apparatus support member wherein one wheel assembly is retractable and comprises a pivoting connector coupled to the base member and a wheel bracket coupled to the pivoting connector. The wheel bracket is adapted to receive an axle and at least one wheel, and is further provided with a handle extending outwardly from the wheel bracket. The handle is used to pivotally rotate the wheel assembly about a transverse axis such that when the handle is rotated away from the base member, the wheel contacts the support surface and the bottom surface of the base member is separated or elevated from the support surface.

    摘要翻译： 一种用于支撑运动装置支撑构件的可滚动运动压载基座，包括具有第一边缘和第二边缘，顶表面和底表面的基部构件。 底表面适于接触诸如车道或其他游戏表面的支撑表面。 至少有一个用于接触支撑表面的轮组件。 车轮组件中的一个可从降低位置缩回到升高位置，使得当处于升高位置时，基座构件的底表面基本上接触支撑表面。 在降低的位置，两个轮组件接触支撑表面，从而使基部构件与支撑表面分离或升高。 在另一个实施例中，本发明由用于支撑运动装置支撑构件的类似的可滚动运动基座组成，其中一个车轮组件可缩回并且包括联接到该基座构件的枢转连接器和联接至该枢转连接器的车轮支架。 车轮支架适于容纳轴和至少一个轮，并且还设置有从车轮支架向外延伸的把手。 手柄用于使车轮组件围绕横向轴线枢转地旋转，使得当手柄远离基座构件旋转时，车轮接触支撑表面，底座构件的底表面与支撑表面分离或升高。